story of the week
IL-6 Receptor Blockade in Treatment-Refractory MOG-IgG–Associated Disease and NMOSD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurology(R) Neuroimmunology & Neuroinflammation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum Disorders
Neurol Neuroimmunol Neuroinflamm 2022 Jan 01;9(1)e1100, M Ringelstein, I Ayzenberg, G Lindenblatt, K Fischer, A Gahlen, G Novi, H Hayward-Könnecke, S Schippling, PS Rommer, B Kornek, T Zrzavy, D Biotti, J Ciron, B Audoin, A Berthele, K Giglhuber, H Zephir, T Kümpfel, R Berger, J Röther, V Häußler, JP Stellmann, D Whittam, A Jacob, M Kraemer, A Gueguen, R Deschamps, A Bayas, MW Hümmert, C Trebst, A Haarmann, S Jarius, B Wildemann, M Grothe, N Siebert, K Ruprecht, F Paul, N Collongues, R Marignier, M Levy, M Karenfort, M Deppe, P Albrecht, K Hellwig, R Gold, HP Hartung, SG Meuth, I Kleiter, O AktasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.